Drug General Information
Drug ID
D0N3NL
Former ID
DNC000151
Drug Name
Acriflavine
Drug Type
Small molecular drug
Indication Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] Phase 1 [525690]
Structure
Download
2D MOL

3D MOL

Formula
C27H25ClN6
Canonical SMILES
C[N+]1=C2C=C(C=CC2=CC3=C1C=C(C=C3)N)N.C1=CC(=CC2=NC3=C(<br />C=CC(=C3)N)C=C21)N.[Cl-]
InChI
1S/C14H13N3.C13H11N3.ClH/c1-17-13-7-11(15)4-2-9(13)6-10-3-5-12(16)8-14(10)17;14-10-3-1-8-5-9-2-4-11(15)7-13(9)16-12(8)6-10;/h2-8H,1H3,(H3,15,16);1-7H,14-15H2;1H
InChIKey
PEJLNXHANOHNSU-UHFFFAOYSA-N
CAS Number
CAS 1811-28-5
PubChem Compound ID
PubChem Substance ID
SuperDrug ATC ID
R02AA13
SuperDrug CAS ID
cas=000086408
Target and Pathway
Target(s) HIV integrase Target Info Modulator [525690]
References
Ref 525690Why have ten or so nontoxic, retrovirus integrase inhibitors not been made available for AIDS treatment. Biomed Pharmacother. 1999 Dec;53(10):484-6.
Ref 525690Why have ten or so nontoxic, retrovirus integrase inhibitors not been made available for AIDS treatment. Biomed Pharmacother. 1999 Dec;53(10):484-6.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.